Cardinal
Cardinal is TransMed7’s application of Zero5 technology to true Fine Needle Core Biopsy (FNCB) for lymph node, thyroid, liver, pancreas and kidney biopsies.
The Technology
The Cardinal product platform of soft tissue biopsy devices has been generated to fulfill the needs of clinicians across medical fields for next-generation, minimally invasive, cost-effective devices designed to safely, reliably, and consistently obtain high-quality Fine Needle Core Biopsy samples for initial and follow-on diagnostic purposes from small tissues of the body and/or from those tissues located in difficult to access areas.
Design Features and Applications
TransMed7’s patented Zero5 technology scalable down to 22 gauge or smaller.
Fine Needle Core Biopsy capabilities for Neurological, Pediatric and Neonatal extremely delicate procedures.
Future Robotic applications for FNCB.
Cardinal is the perfect device for micro-invasive follow-on biopsy sampling to determine if a therapeutic treatment is working. This allows for a gentler repeat biopsy approach while ensuring precision in obtaining the vital information needed for modified therapy options as a disease state evolves, enabling a more holistic and complete new approach to cancer treatment for better patient outcomes.
Health Care Advancements
Zero Collateral Tissue Displacement
Cardinal devices are manufactured in very small sizes and are designed to obtain biopsy samples from small or fragile tissues of the body (such as lymph nodes, thyroid, liver, and pancreas, for example), similar to a procedure called “fine-needle aspiration” (FNA). However, in contrast to fine-needle aspiration technologies, Cardinal devices are designed to have additional capabilities as “fine-needle core biopsy” (FNCB) devices.
This is possible because Cardinal platform technologies use TransMed7’s patented Zero5 technology with a forward-cutting, forward-coring working element designed to obtain solid, full-core, uniform-diameter tissue samples with intact architecture for histopathology analysis, rather than the more limited cytology studies.
Zero Dead Space
As with other devices utilizing TransMed7’s Zero5 technology, there is no “dead space” beyond the tips of the Cardinal beaks, meaning that the working element can obtain core biopsy samples all the way through (and beyond, if desired) the target tissue, thereby minimizing potential damage to important nearby structures (e.g. nerves, blood vessels, neighbouring organs). Cardinal devices are thus designed to be as safe as possible while maintaining a high degree of cost-effectiveness and ease of use, allowing physicians who currently perform fine needle aspirations to readily adapt to using the Cardinal devices.
Cardinal - the new Micro-Invasive Approach
Want to Know More?
please reach out to us using the form below.